Takotsubo Cardiomyopathy
Cardiology
Illness script · Cardiology
Takotsubo Cardiomyopathy
Transient, reversible apical LV ballooning triggered by acute emotional or physical stress, mimicking ACS without obstructive coronary disease.
This illness script for Takotsubo Cardiomyopathy covers predisposing factors, classic presentation, mechanism, workup, management, and the clinical pivots that separate it from look-alikes—written for USMLE Step 1 and clerkship reasoning.
01
Predisposing factors
- Postmenopausal women >90% of cases
- Acute emotional stressor: grief, fear, surprise ('broken heart syndrome')
- Acute physical stressor: surgery, sepsis, stroke, pheochromocytoma
- Low estrogen state (estrogen is cardioprotective against catecholamine surge)
- History of anxiety, depression, or neurological disorders
02
Presentation
- Acute chest pain and dyspnea immediately following identifiable stressor
- ECG: anterior ST elevation → diffuse T-wave inversions + marked QTc prolongation
- Troponin mildly elevated but disproportionately low relative to wall motion abnormality size
- Apical ballooning with hyperkinetic base on echo (octopus-trap shape)
- Can cause cardiogenic shock, LV thrombus, or dynamic LVOT obstruction with MR
03
Pathophysiology
- Massive catecholamine surge causes direct myocardial toxicity and microvascular spasm
- Apical myocardium has highest density of sympathetic nerve terminals → preferentially stunned
- Transient ischemia-like dysfunction without fixed coronary obstruction
- Estrogen deficiency removes protection against adrenergic cardiotoxicity
04
Diagnostics
- ECG first: ST elevation mimics anterior STEMI; QTc prolongation follows
- Troponin mildly elevated — key pearl: extent of WMA far exceeds troponin rise
- Coronary angiography: no obstructive CAD — this is the key differentiator from STEMI
- Echocardiogram: apical ballooning + basal hyperkinesis is pathognomonic wall motion pattern
- LV recovery confirmed on repeat echo at 4–8 weeks
05
Management
- Supportive care: ACEi + beta-blocker for LV dysfunction during acute phase
- Anticoagulate if LV apical thrombus identified on echo
- Avoid catecholamines/dobutamine if LVOT obstruction present — worsens outflow gradient
- Use phenylephrine (pure vasoconstrictor) for LVOTO-related cardiogenic shock instead
- Full LV recovery expected in 1–4 weeks; recurrence risk ~5–10%
06
Clinical pivots
How to separate this script from the look-alikes that show up on exams and on the wards.
Anterior STEMI
Takotsubo has no obstructive CAD on angiography and wall motion abnormality exceeds territory of any single coronary artery.
Myocarditis
Takotsubo has characteristic apical ballooning sparing the base; myocarditis shows diffuse or patchy dysfunction and CMR shows myocardial inflammation/LGE.
Pheochromocytoma-induced cardiomyopathy
Pheo lacks an acute stressor trigger and presents with episodic hypertension; elevated urine/plasma metanephrines distinguish it.
ACS/NSTEMI
In Takotsubo, troponin rise is disproportionately small relative to the large territory of wall motion abnormality — opposite of true ACS.
Keep reading
Full library- Systemic Lupus Erythematosus (SLE)Chronic autoimmune disease with multi-organ involvement driven by loss of tolerance to nuclear antigens and immune complex deposition.
- Tension PneumothoraxAir trapped under pressure in the pleural space causing mediastinal shift, obstructive shock, and cardiorespiratory collapse.
Educational use only. This illness script is a study framework, not medical advice. Confirm decisions with current guidelines and your clinical supervisors.